Healthcare and Pharmaceutical Organizations Praise MicroStrategy's New 7i Business Intelligence Platform


Reduced Costs and Improved Patient Care Among Benefits of Using 7i

McLEAN, Va., May 23, 2002 — MicroStrategy® Incorporated (NASDAQ: MSTR), a leading worldwide provider of business intelligence software, today announced that the new version of its business intelligence platform, MicroStrategy 7i™, is winning praise from leading global companies in the healthcare and pharmaceutical industries. The company said its new platform is designed to help healthcare and pharmaceutical organizations analyze operations, streamline claims processes, reduce costs and improve patient care. Pharmaceutical companies can also use MicroStrategy 7i to monitor and enhance marketing activities to boost sales and brand awareness.

“MicroStrategy business intelligence gives us a better understanding of the market, and helps us meet expected market share goals for our products,” said Keith Megay, senior manager of commercial data warehousing at AstraZeneca. “In addition, the performance and scalability of our MicroStrategy-based application is remarkable, allowing our users to be more productive and efficient.”

“Our employees now have instant access to reports that analyze pharmacy claims via the Internet, saving our customers millions of dollars in erroneous claims,” said Bob Martin, New Business Manager at AIM HealthCare. “We were especially pleased with the rapid deployment capabilities MicroStrategy’s platform allows - we got our applications up and running within two months of installation, enabling us to quickly realize the benefits of our reports.”

“MicroStrategy 7i delivers power, functionality and control securely to users across our enterprise -- analytics to advanced users, extensive reporting functionality to high-level users, and flexibility and control over the application environment to administrators,” said Todd Wilkes, director of applications development at Premier Inc.

According to MicroStrategy, such features as Windows-like functionality over the Web and pure-HTML interfaces in MicroStrategy 7i, make it easy for healthcare and pharmaceutical companies to deploy secure extranet applications. These applications help companies effectively track patient treatment outcomes, identify cost-saving opportunities and improve business processes.

MicroStrategy's current healthcare customers include: Aventis Pasteur, AIM HealthCare, AstraZeneca, Cardinal Health, Dura Pharmacueticals, Forest Laboratories, GlaxoSmithKline, Ingenix, Pharmacia, Premier, Novartis, NDC Heatlh, ProVantage, South Fraser Health, Women's Health.

About MicroStrategy

Leadership in a Critical Market: Founded in 1989, MicroStrategy is a worldwide leader in the increasingly critical business intelligence software market. Large and small companies alike are harnessing MicroStrategy's business intelligence software to gain vital insights from their data to help them proactively enhance cost-efficiency, productivity and customer relations and optimize revenue-generating strategies. MicroStrategy's business intelligence platform offers exceptional capabilities that provide organizations -- in virtually all facets of their operations -- with user- friendly solutions to their data query, reporting, and advanced analytical needs, and distributes valuable insight on this data to users via Web, wireless, and voice. PC Magazine selected MicroStrategy 7™ as the 2001 "Editors' Choice" for business intelligence software.

Enterprise-Class Business Intelligence: MicroStrategy 7i™ is a truly integrated, enterprise-class, Web-based business intelligence platform. With MicroStrategy 7i, enterprises can now standardize on one business intelligence platform and deploy high-value business intelligence enterprise-wide. MicroStrategy 7i's configurable query, reporting, and OLAP Web interface is designed to support all users, from casual report viewers to power analysts.

Diverse Customer Base: MicroStrategy's customer base cuts across industry and sector lines, with over 1,500 enterprise-class customers, including Lowe's Home Improvement Warehouse, AT&T Wireless Group, Wachovia and GlaxoSmithKline. MicroStrategy also has relationships with over 400 systems integrators and application development and platform partners, including IBM, PeopleSoft, Compaq, and JD Edwards.

MicroStrategy is listed on Nasdaq under the symbol MSTR. For more information on the company, or to purchase or demo MicroStrategy's software, please visit MicroStrategy's Web site at http://www.microstrategy.com.


MicroStrategy, MicroStrategy 7, MicroStrategy 7i are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.


This press release may include statements that may constitute "forward- looking statements," including its estimates of future business prospects or financial results and statements containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results of MicroStrategy Incorporated and its subsidiaries (collectively, the "Company") to differ materially from the forward-looking statements. Factors that could contribute to such differences include: the possibility that the conditions to the securities class action and shareholder derivative settlement agreements will not be satisfied; the Company's ability to secure financing for its current operations and long-term plans on acceptable terms; the ability of the Company to implement and achieve widespread customer acceptance of its MicroStrategy 7 software on a timely basis; the Company's ability to recognize deferred revenue through delivery of products or satisfactory performance of services; the timely release of the MicroStrategy 7i platform; continued acceptance of the Company's products in the marketplace; the timing of significant orders; delays in the Company's ability to develop or ship new products; market acceptance of new products; competitive factors; general economic conditions; currency fluctuations and other risks detailed in the Company's registration statements and periodic reports filed with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Contact:

Alka Nayyar
MicroStrategy Incorporated
(703) 847-4897
anayyar@microstrategy.com